Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
2005-000071-18Phase 4Completed
Phase 4, open-label trial of teicoplanin in bacterial disease and Staphylococcosis (2 cohorts), sponsored by Medical University of South Carolina. Primary endpoints: Maximum plasma concentration, Area under the concentration-time curve and 5 more. Started Mar 2005; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on 2005-000071-18.